<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">OJOG</journal-id><journal-title-group><journal-title>Open Journal of Obstetrics and Gynecology</journal-title></journal-title-group><issn pub-type="epub">2160-8792</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/ojog.2019.99121</article-id><article-id pub-id-type="publisher-id">OJOG-94942</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine&amp;Healthcare</subject></subj-group></article-categories><title-group><article-title>
 
 
  Getting Pregnant after Infertility Management without Assisted Reproductive Technology in a Low-Income Setting
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>E.</surname><given-names>Mboloko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>A.</surname><given-names>N. Apangwa</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>E.</surname><given-names>Nzau-Ngoma</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>Mboloko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>B.</surname><given-names>G. Malingisi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>B.</surname><given-names>C. J. Bikuelo</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>M.</surname><given-names>M. M. Kapend</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>L.</surname><given-names>Mputu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Cliniques Universitaires de Kinshasa, Université de Kinshasa, Kinshasa, Congo</addr-line></aff><pub-date pub-type="epub"><day>05</day><month>09</month><year>2019</year></pub-date><volume>09</volume><issue>09</issue><fpage>1250</fpage><lpage>1264</lpage><history><date date-type="received"><day>9,</day>	<month>August</month>	<year>2019</year></date><date date-type="rev-recd"><day>7,</day>	<month>September</month>	<year>2019</year>	</date><date date-type="accepted"><day>10,</day>	<month>September</month>	<year>2019</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Getting pregnant after infertility management is a more challenging situation 
  in some under equipped sub-Saharan setting. To highlight the determinants of conception without Assisted Reproductive technology (ART)
   
  in a
   low-
  income area. The current study concerned 2958 patients who sought care for infertility in the University Clinic of Kinshasa et the Centre Medical Edith, from January 2003 to December 2013. For them, any technique of ART was used. Age of patients ranged from 18 to 49 with average of 33.2 
  &#177; 5.6 years old. After treatment
  ,
   249
   
  (9%) patients conceived (clinical pregnancy). Most of the patients who conceived were less 
  than 
  36 years, without history of illegal abortions et who suffered from genital infections. The treatments closely associated 
  with
   conception were antibiotics (73%), hydrotubation (12%) ovulation
   
  inductors (11%) and gynecologic surgery (4%). In that setting, ART is a must
  .
   Very few infertility problems, apart from infection and its conse
  quences, can get solution.
 
</p></abstract><kwd-group><kwd>Infertility Management</kwd><kwd> Sub-Saharan Area</kwd><kwd> ART</kwd><kwd> Tubal Infertility</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Getting pregnant after infertility management is a more challenging situation in some under equipped sub-Saharan area. In spite of the high prevalence of infertility (25% - 30%), relevant care, represented by Assisted Reproductive techniques (ART) are not only generally unavailable, but more expensive in most of those settings where they are implemented [<xref ref-type="bibr" rid="scirp.94942-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.94942-ref2">2</xref>] . Resorting to former attitudes without ART is then the rule.</p><p>Couple infertility, defined as the failure to conceive after at least a year of regular and complete intercourse without any contraception, is a worldwide public health problem [<xref ref-type="bibr" rid="scirp.94942-ref3">3</xref>] [<xref ref-type="bibr" rid="scirp.94942-ref4">4</xref>] [<xref ref-type="bibr" rid="scirp.94942-ref5">5</xref>] ; especially in sub Saharan setting [<xref ref-type="bibr" rid="scirp.94942-ref6">6</xref>] . The tuboperitoneal lesions from infectious origin constitute the main cause of infertility [<xref ref-type="bibr" rid="scirp.94942-ref7">7</xref>] . That region is among pronatalists areas where infertility is a source of social dramatic consequences like: stigmatization, reject, divorce, polygamy and depression [<xref ref-type="bibr" rid="scirp.94942-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.94942-ref9">9</xref>] . Belonging to a strong growth demographic region, secondary infertility is the most prevalent. Indeed, with a high desire to procreate, there is less attention to use contraceptive method, like barrier, that prevent also from sexual transmitted infection (STI) [<xref ref-type="bibr" rid="scirp.94942-ref10">10</xref>] .</p><p>The STI with postpartum infection are the main cause of tubal infertility by tubal occlusion among with, peritoneal and peritubo ovarian adhesions. Assisted Reproductive Techniques (ART) constitutes the relevant way to take care of those patients. Unfortunately, they are unavailable in some sub-Saharan areas because of the difficulties to acquire equipment; and the way many government’s decision makers perceive the problem of infertility [<xref ref-type="bibr" rid="scirp.94942-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.94942-ref11">11</xref>] . According to WHO, the Reproductive health is a complete well being of people concerning genital apparatus: its function and its functionality, not only the absence of disease. That definition takes in account, couple infertility and its consequences [<xref ref-type="bibr" rid="scirp.94942-ref12">12</xref>] . Unfortunately, in many sub-Saharan countries, Reproductive health is reduced to contraception methods. So, organizing facilities to take care of infertility is considered as spending money for free. In the other hand, ARTs are so expensive (cost of ovulation inductors and investigations) that few can afford that by themselves [<xref ref-type="bibr" rid="scirp.94942-ref11">11</xref>] . In that situation many medical institutions providing infertility care don’t dispose of ART facilities.</p><p>Until 2013, more than 450 ART centers were available in USA, with 12,000 dollars for one tentative; supported by the patient; in France, 106 centers with 2500$ a tentative, supported by social security facilities [<xref ref-type="bibr" rid="scirp.94942-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.94942-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.94942-ref15">15</xref>] . In Africa continent, few centers providing ART were available [<xref ref-type="bibr" rid="scirp.94942-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.94942-ref17">17</xref>] : three in Kenya and one in DRC, where cares are supported by the patients themselves. Consequently, many infertile patients were treated without using ARTs.</p><p>The aim of the current study is to highlight the determinants of conception in a program of infertility management out of ARTs, in a low-income setting.</p></sec><sec id="s2"><title>2. Material and Methods</title><p>It was a case-control study that took place from January 2003 to December 2013, in the University Clinic of Kinshasa (infertility unit) and the Centre Medical Edith (whose main activity is infertility care). The two facilities used the same infertility management protocols. A total of 2958 patients, who were managed without any ART (Intra uterine insemination, in vitro fertilization and Intracytoplasmic sperm injection), were enrolled. Among them, only 2913, who were followed during at least six months, were included in the current study and 45 were excluded because of the incompleteness of their files, genital tract malformations and age above 49 years old. They were divided into two groups: the case group was made of patients who conceived after investigations and treatment; the control group by the ones who did not conceive.</p><p>Their management was systematically made of: anamnesis (the main complaint and medical history), physical examination, Para clinical investigations: hysterosalpingography (HSG), endometrial biopsy (using Novak canula), postco&#239;tal test (PCT), and spermogram; after that, some further investigations were made, according to the previous findings. Hence a diagnosis has been made and a relevant treatment was applied: medical treatment (specially Antibiotics, ovulation inductors), surgery (specially myomectomy, intrauterine synechiae lysis, adhesiolysis, salpingostomy and fimbryiolysis).</p><p>The variables of interest were demographics: the age of the patient and her partner, parity, history of abortion, duration of infertility (period from maternity desire to the day of consultation); medical, obstetrical and surgery histories (mainly abdomino-pelvic surgeries); marital status (free union, monogamic or polygamic), clinic: BMI and Para clinic findings: Hysterosalpingography, endometrial biopsy (novak canula), Post co&#239;tal test and spermogram. Given that the main etiologies of infertility are of tubal origin in sub Saharan area, HSG is the key test to be considered that the patient was well investigated para clinically in the current study. To stay in the level of infertility management of that period, in most of the centers in that setting, the laparoscopic and hysteroscopy findings were not taken in account. Several years ago, endometrial biopsy and post coital test were counted among our usual infertility workup. Endometrial biopsy at mi-luteal phase to check the functional aspect of the secretory phase (concordance between the day of the cycle and the endometrium aspect) and the organic lesion of endometrium (specific and non-specific endometritis, bone metaplasia). The PCT was used to assess, under the high-power objective, the presence of sperm; their number and their motility in contact with cervical mucus. It was considered positive when at least 5 sperms were observed per one high power field of microscope, and negative in the absence of sperm, or the presence of less than 5 motile sperms or immotile sperm. Because of male partner reticence to be examined, only the ones with negative PCT were selected for spermogram, in the current study. We considered as pauciparous, the patients who delivered two or three viable fetus (≥28 weeks of gestational age) and multiparous, above three. For the BMI (weight per height in square meter), patients were categorized according to the WHO classification [<xref ref-type="bibr" rid="scirp.94942-ref18">18</xref>] .</p><p>Data were extracted, respectively from the database of University clinic infertility unit and the Centre M&#233;dical Edith and recorded in an MS access database; missing informations were completed from patients’ files. The Stata IC 15.1 program analyzed the data. Quantitative variables were summarized as mean and standard deviation; qualitative variables as proportion. The Pearson Khi2 test was used for proportions comparison; the t Student test for means comparison and logistic regression to appreciate the strength of association between variables. The significative difference level was set at p = 0.05.</p><p>The current study had received the approval of the Gynecology and Obstetrics Department of Kinshasa University clinic board.</p><p>There was no conflict of interest in the current study.</p></sec><sec id="s3"><title>3. Results</title><p>1) General patients’ characteristics</p><p>The mean age of patients was 33.2 &#177; 5.6 years and ranged from 18 to 49 years old. Most of them (34.3%) were above 35 years, followed by those between 31 to 35 (32.1%). The mean age of menarche was 13.8 &#177; 1.8 years ranging from 8 to 22 years. The majority of patients were nulliparous (62.9%), three percent (2.8%) were multiparous and two third (65.6%) had secondary infertility. Forty percent of the patients had a history of at least one illegal abortion. Almost all of them (97.4%) were married.</p><p>The male partners mean age was 40.3 &#177; 6.3 years old with the extreme of 24 and 74 years. The majority of them (51.7%) were between 31 and 40 years old. Mean infertility duration was 4.3 &#177; 3.7 years with a quarter (26.6 %) having consulted after 5 years of infertility. Forty-one percent had a history of previous abdomno pelvic surgery, among them appendicectomy (13%) and myomectomy (8.9%) were the most frequent. Most of patients were overweight (39.6%) and a fifth (20.1%) frankly obese.</p><p>After first visit and preliminary investigations, genital infection (low and high genital infection) was the most frequent main diagnosis (46.7%) followed by uterus myoma (21.9%).</p><p>At hysterosalpingography (for 1219 patients) almost a half (46.5%) had tubal occlusion with 33.5% bilateral occlusion. The endometrial biopsy revealed 43 (5.04%) patients with endometritis; among them 38 cases (88.3%) of nonspecific endometritis and 2 (4.6%) of tuberculosis endometritis. Among the 647 spermograms, 75% were abnormal (52% oligoasthenozoospermia, 18% oligozoospermia; 4% azoospermia and 1% oligoasthenoteratozoospermia). According to the diagnosis, different treatments were applied.</p><p>2) Conception among those patients</p><p>From the 2913 patients who attending infertility clinic, 249 conceived (9%). To consider the treatment immediately followed by conception, we had antibiotics in 73% patients, ovulation inductors in 11%, the actually abandoned hydrotubation in 12% and surgery in 4% (<xref ref-type="fig" rid="fig1">Figure 1</xref>).</p><p>Mean age of the case group was lesser (31.3 &#177; 5.0 years) than the control (33.4 &#177; 5.6 years) (p = 0.000). Furthermore, the case group partners mean age was lesser (37.8 &#177; 5.7 years) than the controls partners (40.5 &#177; 6.0) (p = 0.000). According to <xref ref-type="table" rid="table1">Table 1</xref>, below 36 years, 11% of patients conceived vs 4.2% above (p = 0.000). There was no difference (p = 0.5) between the rate of conception between primary infertility patients (9.3%) compared to secondary (8.6%). Illegal</p><table-wrap-group id="1"><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Patients’ characteristics and conception</title></caption><table-wrap id="1_1"><table><tbody><thead><tr><th align="center" valign="middle" ></th><th align="center" valign="middle" >Total N</th><th align="center" valign="middle" >Without conception n</th><th align="center" valign="middle" >Conception n</th><th align="center" valign="middle" >%</th><th align="center" valign="middle" >p</th></tr></thead><tr><td align="center" valign="middle" >AGE (years)</td><td align="center" valign="middle" >2889</td><td align="center" valign="middle" >2640</td><td align="center" valign="middle" >249</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≤25</td><td align="center" valign="middle" >240</td><td align="center" valign="middle" >213</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >11.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >26 - 30</td><td align="center" valign="middle" >729</td><td align="center" valign="middle" >646</td><td align="center" valign="middle" >83</td><td align="center" valign="middle" >11.4</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >31 - 35</td><td align="center" valign="middle" >928</td><td align="center" valign="middle" >831</td><td align="center" valign="middle" >97</td><td align="center" valign="middle" >10.4</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;35</td><td align="center" valign="middle" >992</td><td align="center" valign="middle" >950</td><td align="center" valign="middle" >42</td><td align="center" valign="middle" >4.2</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Average</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >33.4 &#177; 5.6</td><td align="center" valign="middle" >31.3 &#177; 5</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >TYPE OF INFERTILITY</td><td align="center" valign="middle" >2739</td><td align="center" valign="middle" >2496</td><td align="center" valign="middle" >243</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >I</td><td align="center" valign="middle" >942</td><td align="center" valign="middle" >854</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >9.3</td><td align="center" valign="middle" >0.499</td></tr><tr><td align="center" valign="middle" >II</td><td align="center" valign="middle" >1797</td><td align="center" valign="middle" >1642</td><td align="center" valign="middle" >155</td><td align="center" valign="middle" >8.6</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >ILLEGAL ABORTION</td><td align="center" valign="middle" >1804</td><td align="center" valign="middle" >1597</td><td align="center" valign="middle" >207</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >0</td><td align="center" valign="middle" >1089</td><td align="center" valign="middle" >939</td><td align="center" valign="middle" >150</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1 - 2</td><td align="center" valign="middle" >595</td><td align="center" valign="middle" >544</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >8.6</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >≥3</td><td align="center" valign="middle" >120</td><td align="center" valign="middle" >114</td><td align="center" valign="middle" >6</td><td align="center" valign="middle" >5</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Marital STATUS</td><td align="center" valign="middle" >2713</td><td align="center" valign="middle" >2477</td><td align="center" valign="middle" >236</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Married</td><td align="center" valign="middle" >2642</td><td align="center" valign="middle" >2408</td><td align="center" valign="middle" >234</td><td align="center" valign="middle" >8.9</td><td align="center" valign="middle" >0.075</td></tr><tr><td align="center" valign="middle" >Single</td><td align="center" valign="middle" >71</td><td align="center" valign="middle" >69</td><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >INFERTILITY DURATION (years)</td><td align="center" valign="middle" >1468</td><td align="center" valign="middle" >1277</td><td align="center" valign="middle" >191</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >297</td><td align="center" valign="middle" >233</td><td align="center" valign="middle" >64</td><td align="center" valign="middle" >21.6</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >299</td><td align="center" valign="middle" >250</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >16</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >3 - 5</td><td align="center" valign="middle" >482</td><td align="center" valign="middle" >431</td><td align="center" valign="middle" >51</td><td align="center" valign="middle" >10.6</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&gt;5</td><td align="center" valign="middle" >390</td><td align="center" valign="middle" >363</td><td align="center" valign="middle" >27</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >ABDOMINO PELVIC SURGERY HISTORY</td><td align="center" valign="middle" >2908</td><td align="center" valign="middle" >2659</td><td align="center" valign="middle" >249</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No history</td><td align="center" valign="middle" >1718</td><td align="center" valign="middle" >1554</td><td align="center" valign="middle" >164</td><td align="center" valign="middle" >9.5</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Appendicectomy</td><td align="center" valign="middle" >378</td><td align="center" valign="middle" >340</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >10.1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >kystectomy</td><td align="center" valign="middle" >93</td><td align="center" valign="middle" >89</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >4.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Myomectomy</td><td align="center" valign="middle" >261</td><td align="center" valign="middle" >246</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >5.7</td><td align="center" valign="middle" >0.150</td></tr><tr><td align="center" valign="middle" >kystectomy &amp; appendicectomy</td><td align="center" valign="middle" >148</td><td align="center" valign="middle" >138</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >6.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Ceasarian</td><td align="center" valign="middle" >44</td><td align="center" valign="middle" >40</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >9.1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Ectopic pregnancy</td><td align="center" valign="middle" >38</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >2.6</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Adhesiolysis &amp; stomatoplasty</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Peritonitis</td><td align="center" valign="middle" >11</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >207</td><td align="center" valign="middle" >195</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >5.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >BODY MASS INDEX</td><td align="center" valign="middle" >920</td><td align="center" valign="middle" >777</td><td align="center" valign="middle" >143</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;18.5</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >19</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >17.3</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><table-wrap id="1_2"><table><tbody><thead><tr><th align="center" valign="middle" >18.5 - 24.9</th><th align="center" valign="middle" >345</th><th align="center" valign="middle" >271</th><th align="center" valign="middle" >74</th><th align="center" valign="middle" >21.4</th><th align="center" valign="middle" >0.001</th></tr></thead><tr><td align="center" valign="middle" >25 – 29.9</td><td align="center" valign="middle" >366</td><td align="center" valign="middle" >321</td><td align="center" valign="middle" >45</td><td align="center" valign="middle" >12.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≥30</td><td align="center" valign="middle" >186</td><td align="center" valign="middle" >166</td><td align="center" valign="middle" >20</td><td align="center" valign="middle" >10.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >C</td><td align="center" valign="middle" ></td><td align="center" valign="middle" >26.73 &#177; 5.15</td><td align="center" valign="middle" >25.25 &#177; 4.3</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >DIAGNOSIS</td><td align="center" valign="middle" >1122</td><td align="center" valign="middle" >1122</td><td align="center" valign="middle" >149</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Genital infection</td><td align="center" valign="middle" >524</td><td align="center" valign="middle" >468</td><td align="center" valign="middle" >56</td><td align="center" valign="middle" >10.7</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Myoma</td><td align="center" valign="middle" >246</td><td align="center" valign="middle" >229</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >6.9</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Ovarian dystrophy (SOMPK)</td><td align="center" valign="middle" >96</td><td align="center" valign="middle" >79</td><td align="center" valign="middle" >17</td><td align="center" valign="middle" >17.7</td><td align="center" valign="middle" >0.000</td></tr><tr><td align="center" valign="middle" >Hyperprolactinemia</td><td align="center" valign="middle" >70</td><td align="center" valign="middle" >53</td><td align="center" valign="middle" >18</td><td align="center" valign="middle" >24.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Uterine synechia</td><td align="center" valign="middle" >34</td><td align="center" valign="middle" >30</td><td align="center" valign="middle" >4</td><td align="center" valign="middle" >11.8</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >No diagnosis</td><td align="center" valign="middle" >152</td><td align="center" valign="middle" >115</td><td align="center" valign="middle" >37</td><td align="center" valign="middle" >24.3</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HSG</td><td align="center" valign="middle" >1219</td><td align="center" valign="middle" >1083</td><td align="center" valign="middle" >136</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >439</td><td align="center" valign="middle" >381</td><td align="center" valign="middle" >58</td><td align="center" valign="middle" >13.2</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >BTO</td><td align="center" valign="middle" >408</td><td align="center" valign="middle" >359</td><td align="center" valign="middle" >49</td><td align="center" valign="middle" >12</td><td align="center" valign="middle" >0.073</td></tr><tr><td align="center" valign="middle" >UTO</td><td align="center" valign="middle" >158</td><td align="center" valign="middle" >143</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" >9.5</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Adhesions, adenomyosis</td><td align="center" valign="middle" >214</td><td align="center" valign="middle" >200</td><td align="center" valign="middle" >14</td><td align="center" valign="middle" >6.5</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Endometrial biopsy</td><td align="center" valign="middle" >854</td><td align="center" valign="middle" >854</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >162</td><td align="center" valign="middle" >139</td><td align="center" valign="middle" >23</td><td align="center" valign="middle" >14.1</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Functional abnormalities</td><td align="center" valign="middle" >649</td><td align="center" valign="middle" >577</td><td align="center" valign="middle" >72</td><td align="center" valign="middle" >11.1</td><td align="center" valign="middle" >0.369</td></tr><tr><td align="center" valign="middle" >Endometritis</td><td align="center" valign="middle" >43</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >7</td><td align="center" valign="middle" >16.2</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >SPERMOGRAM</td><td align="center" valign="middle" >647</td><td align="center" valign="middle" >647</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >161</td><td align="center" valign="middle" >137</td><td align="center" valign="middle" >24</td><td align="center" valign="middle" >14.9</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >oligozoospermia</td><td align="center" valign="middle" >115</td><td align="center" valign="middle" >105</td><td align="center" valign="middle" >10</td><td align="center" valign="middle" >8.7</td><td align="center" valign="middle" >0.059</td></tr><tr><td align="center" valign="middle" >oligoasthenozoospermia</td><td align="center" valign="middle" >334</td><td align="center" valign="middle" >284</td><td align="center" valign="middle" >50</td><td align="center" valign="middle" >15</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Oligoasthenotheratozoospemia</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >9</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Azoospermia</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >28</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" >0</td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >LEUCOSPERMIA</td><td align="center" valign="middle" >647</td><td align="center" valign="middle" >647</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >sperm with leucospermia</td><td align="center" valign="middle" >315</td><td align="center" valign="middle" >267</td><td align="center" valign="middle" >48</td><td align="center" valign="middle" >15.2</td><td align="center" valign="middle" >0.096</td></tr><tr><td align="center" valign="middle" >sperm Without leucospermia</td><td align="center" valign="middle" >332</td><td align="center" valign="middle" >296</td><td align="center" valign="middle" >36</td><td align="center" valign="middle" >10.8</td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap></table-wrap-group><p>Legend: N = total number of patients; n = number of patients who conceived; % = their percentage. Infertility I = primary; II: secondary.</p><p>abortion was more (p = 0.000) frequent (41.2%) among the controls than the cases (27.54%). The conception frequency decreased with the number of illegal abortion (p = 0.000): from 14% for patients without history of illegal abortion to 5% for the ones with more two abortion (<xref ref-type="table" rid="table2">Table 2</xref>).</p><p>Almost all the patients were married (99.15% vs 97.21%); no difference between married and singles for conception rate (p = 0.075). The percentage of the patients who conceived decreased steadily (p = 0.000) with the infertility duration:</p><table-wrap-group id="2"><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Conception determinants in univariate analysis</title></caption><table-wrap id="2_1"><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >OR</th><th align="center" valign="middle" >SE</th><th align="center" valign="middle" >p</th><th align="center" valign="middle" >IC 95%</th></tr></thead><tr><td align="center" valign="middle" >Age of patients (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≤25</td><td align="center" valign="middle" >2.867</td><td align="center" valign="middle" >0.739</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >1.729 - 4.754</td></tr><tr><td align="center" valign="middle" >26 - 30</td><td align="center" valign="middle" >2.906</td><td align="center" valign="middle" >0.569</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >1.978 - 4.268</td></tr><tr><td align="center" valign="middle" >31 - 35</td><td align="center" valign="middle" >2.640</td><td align="center" valign="middle" >0.503</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >1.816 - 3.836</td></tr><tr><td align="center" valign="middle" >&gt;35</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type of infertility</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Infer II</td><td align="center" valign="middle" >0.909</td><td align="center" valign="middle" >0.127</td><td align="center" valign="middle" >0.499</td><td align="center" valign="middle" >0.691 - 1.197</td></tr><tr><td align="center" valign="middle" >Infer I</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Illegal abortion</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1 - 2</td><td align="center" valign="middle" >0.586</td><td align="center" valign="middle" >0.100</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >0.419 - 0.820</td></tr><tr><td align="center" valign="middle" >≥3</td><td align="center" valign="middle" >0.329</td><td align="center" valign="middle" >0.141</td><td align="center" valign="middle" >0.009</td><td align="center" valign="middle" >0.142 - 0.762</td></tr><tr><td align="center" valign="middle" >none</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Partner age (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >≤30</td><td align="center" valign="middle" >1.714</td><td align="center" valign="middle" >0809</td><td align="center" valign="middle" >0,254</td><td align="center" valign="middle" >0.679 - 4.324</td></tr><tr><td align="center" valign="middle" >31 - 40</td><td align="center" valign="middle" >2.002</td><td align="center" valign="middle" >0714</td><td align="center" valign="middle" >0,052</td><td align="center" valign="middle" >0.995 - 4.029</td></tr><tr><td align="center" valign="middle" >41 - 50</td><td align="center" valign="middle" >0.578</td><td align="center" valign="middle" >0222</td><td align="center" valign="middle" >0,155</td><td align="center" valign="middle" >0.272 - 1.230</td></tr><tr><td align="center" valign="middle" >&gt;50</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >18.5 - 24.9</td><td align="center" valign="middle" >0.525</td><td align="center" valign="middle" >0.331</td><td align="center" valign="middle" >0.307</td><td align="center" valign="middle" >0.152 - 1.808</td></tr><tr><td align="center" valign="middle" >25 - 29.9</td><td align="center" valign="middle" >0.520</td><td align="center" valign="middle" >0.107</td><td align="center" valign="middle" >0.002</td><td align="center" valign="middle" >0.347 - 0.779</td></tr><tr><td align="center" valign="middle" >≥30</td><td align="center" valign="middle" >0.442</td><td align="center" valign="middle" >0.119</td><td align="center" valign="middle" >0.003</td><td align="center" valign="middle" >0.260 - 0.752</td></tr><tr><td align="center" valign="middle" >&lt;18.5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Diagnosis</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Genital infection</td><td align="center" valign="middle" >1.829</td><td align="center" valign="middle" >0.758</td><td align="center" valign="middle" >0.146</td><td align="center" valign="middle" >0.810 - 4.125</td></tr><tr><td align="center" valign="middle" >Myoma</td><td align="center" valign="middle" >1.134</td><td align="center" valign="middle" >0.526</td><td align="center" valign="middle" >0.785</td><td align="center" valign="middle" >0.456 - 2.810</td></tr><tr><td align="center" valign="middle" >Ovarian Dystrophy</td><td align="center" valign="middle" >3.289</td><td align="center" valign="middle" >1.555</td><td align="center" valign="middle" >0.012</td><td align="center" valign="middle" >1.301 - 8.311</td></tr><tr><td align="center" valign="middle" >Hyperprolactinemia</td><td align="center" valign="middle" >4.902</td><td align="center" valign="middle" >2.350</td><td align="center" valign="middle" >0.001</td><td align="center" valign="middle" >1.915 - 12.548</td></tr><tr><td align="center" valign="middle" >Synechia</td><td align="center" valign="middle" >2.038</td><td align="center" valign="middle" >1.345</td><td align="center" valign="middle" >0.281</td><td align="center" valign="middle" >0.559 - 7.429</td></tr><tr><td align="center" valign="middle" >Menopausis</td><td align="center" valign="middle" >Omitted</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Cycle desorders</td><td align="center" valign="middle" >3.668</td><td align="center" valign="middle" >2.197</td><td align="center" valign="middle" >0.030</td><td align="center" valign="middle" >1.133 - 11.869</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HSG</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >BTO</td><td align="center" valign="middle" >0.814</td><td align="center" valign="middle" >0.172</td><td align="center" valign="middle" >0.332</td><td align="center" valign="middle" >0.537 - 1.233</td></tr><tr><td align="center" valign="middle" >UTO</td><td align="center" valign="middle" >0.689</td><td align="center" valign="middle" >0.210</td><td align="center" valign="middle" >0.223</td><td align="center" valign="middle" >0.378 - 1.254</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >0.459</td><td align="center" valign="middle" >0.142</td><td align="center" valign="middle" >0.012</td><td align="center" valign="middle" >0.250 - 0.844</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Endometrial biopsy</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Functional abnormalies</td><td align="center" valign="middle" >0.754</td><td align="center" valign="middle" >0.194</td><td align="center" valign="middle" >0.273</td><td align="center" valign="middle" >0.455 - 1.249</td></tr></tbody></table></table-wrap><table-wrap id="2_2"><table><tbody><thead><tr><th align="center" valign="middle" >Endometritis</th><th align="center" valign="middle" >1.175</th><th align="center" valign="middle" >0.552</th><th align="center" valign="middle" >0.732</th><th align="center" valign="middle" >0.467 - 2.954</th></tr></thead><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Spermogram</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Oligospermia</td><td align="center" valign="middle" >0.543</td><td align="center" valign="middle" >0.216</td><td align="center" valign="middle" >0.126</td><td align="center" valign="middle" >0.249 - 1.186</td></tr><tr><td align="center" valign="middle" >Oligoasthenozoospermia</td><td align="center" valign="middle" >1.004</td><td align="center" valign="middle" >0.270</td><td align="center" valign="middle" >0.985</td><td align="center" valign="middle" >0.592 - 1.703</td></tr><tr><td align="center" valign="middle" >OAT</td><td align="center" valign="middle" >Omitted</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Azoospermia</td><td align="center" valign="middle" >Omitted</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Duration of infertility (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >3.692</td><td align="center" valign="middle" >0.902</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >2.287 - 5.961</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >2.571</td><td align="center" valign="middle" >0.653</td><td align="center" valign="middle" >0.000</td><td align="center" valign="middle" >1.562 - 4.231</td></tr><tr><td align="center" valign="middle" >3 - 5</td><td align="center" valign="middle" >1.590</td><td align="center" valign="middle" >0.395</td><td align="center" valign="middle" >0.062</td><td align="center" valign="middle" >0.977 - 2.588</td></tr><tr><td align="center" valign="middle" >&gt;5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap></table-wrap-group><p>Legend: OAT = oligoasthenozoospermia; BTO = Bilateral tubal occlusion; UTO = Unilateral tubal occlusion; Others = synechiae, spicules.</p><p>21.5% after a year; 16% after two years and 7% after 5 years).</p><p>A third of the two groups (34.2% and 39.6%) had a history of abdomino-pelvic surgery, with appendicectomy as the most frequent (13%). There was no difference (p = 0.150) between the surgeries indication and the conception rate.</p><p>The mean BMI of the case group (25.23 &#177; 4.3) was less (p = 0.0014) than controls’ (26.73 &#177; 5.18). Obesity was more frequent (21.28% vs 13.92%) among controls (p = 0.0014) than case group. In comparison with the normoweighted group; the rate of conception was low in thinness category and decreased with the BMI above 30 kg/m<sup>2</sup> (0.001). Genital infection, after physical examination and first line investigations, was the main diagnosis (22.67% vs 17.68%) but more frequent among the ones who conceived (0.000); and myoma more frequent in control group (8.66% VS 6.88%) (p = 0.000). According to <xref ref-type="table" rid="table2">Table 2</xref>, there was no difference between case group and control regarding HSG (p = 0.073) and endometrial biopsy (p = 0.059) findings for conception. The majority patients (44.45% vs 46.5% had any tubal occlusion (bilateral tubal occlusion: 34.39% vs 33.39%). A tenth (12%) of patients with BTO conceived. Among the patients with endometritis, sixteen percent conceived after treatment.</p><p>3) Determinants of Conception</p><p>The variables significantly associated with conception were the age of patients and of their partners, BMI and the number of illegal abortions.</p><p>Patients of less than 36 years old had three times more chance to conceive than the ones above; especially for those of 25 - 30 years cluster (OR = 2.9; 95% IC: 1.978 - 4.286). Overweight and obesity were associated with the reduction of the chance of conception in comparison to the thinness (p = 0.002 and p = 0.03). The chance of conception decreased with the number of illegal abortions: a history of 1 to 2 abortion reduced the chance of conception of 42% (p = 0.002) and 70% (p = 0.009) from 3 abortions. Patients whose male partners was less than 41 years old had twice more chance to conceive compared to those whose partners had more than 40 years old; this association was at the edge of significance (p = 0.052).</p><p>The chance to conceive decreased with the duration of infertility: one year, two and 3 to 5 years clusters were associated with respectively four, three and two times more chance to conceive than the ones above 5 years (p = 0.000). Patients with tubo-peritoneal lesions at HSG had the chance of conception decreased of 20% for BTO; 30% for UTO and 55% for others (deformation of uterine cavity, adenomyosis) compared with those without.</p><p>In multivariate analysis (<xref ref-type="table" rid="table3">Table 3</xref>), the age of patients, the BMI remained significantly (p = 0.017 and 0.028) associated with conception. In comparison with those of more than 35 years, patients of less than 25 and 31 - 35 clusters had respectively 24 and 6 times more chance to conceive (p = 0.017 and 0.028). The chance of conception was reduced by 95% for overweight patients (p = 0.033) than the thins.</p></sec><sec id="s4"><title>4. Discussion</title><p>1) General Patients Characteristics</p><p>The average age of the patients was 33.2 &#177; 5.6 years raging from 18 to 49. That was close to our findings in 2011: 33.7 &#177; 5.2 years old [<xref ref-type="bibr" rid="scirp.94942-ref19">19</xref>] . In the contrary, that mean age was superior to the ones, found by our team 15 years before [<xref ref-type="bibr" rid="scirp.94942-ref20">20</xref>] , by Ciss&#233; et al., 1997 [<xref ref-type="bibr" rid="scirp.94942-ref21">21</xref>] and Moreira, 2008 in Senegal [<xref ref-type="bibr" rid="scirp.94942-ref17">17</xref>] respectively: 29.5; 26 and 28 years. That observation is consistent with Belaish et al., 2009 who noticed the increase of age at first motherhood year by year, in the world. Many women get married more and more later [<xref ref-type="bibr" rid="scirp.94942-ref22">22</xref>] . Furthermore, the high rate of illegal abortions among patients (40%) pleads for great sexual activity meanwhile, without contraception barrier, that constituted a risk factor for sexual transmitted infection and its consequence leading to tubal infertility.</p><table-wrap id="table3" ><label><xref ref-type="table" rid="table3">Table 3</xref></label><caption><title> Conception determinants in multivariate analysis</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Variables</th><th align="center" valign="middle" >OR</th><th align="center" valign="middle" >SE</th><th align="center" valign="middle" >p</th><th align="center" valign="middle" >IC 95%</th></tr></thead><tr><td align="center" valign="middle" >Age of patientes (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >&lt;25</td><td align="center" valign="middle" >24.350</td><td align="center" valign="middle" >32.577</td><td align="center" valign="middle" >0.017</td><td align="center" valign="middle" >1.768 - 335.203</td></tr><tr><td align="center" valign="middle" >26 - 30</td><td align="center" valign="middle" >1.731</td><td align="center" valign="middle" >1.616</td><td align="center" valign="middle" >0.556</td><td align="center" valign="middle" >0.278 - 10.786</td></tr><tr><td align="center" valign="middle" >31 - 35</td><td align="center" valign="middle" >5.935</td><td align="center" valign="middle" >4.802</td><td align="center" valign="middle" >0.028</td><td align="center" valign="middle" >1.215 - 28.984</td></tr><tr><td align="center" valign="middle" >&gt;35</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Type of infertility</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Infer II</td><td align="center" valign="middle" >1.952</td><td align="center" valign="middle" >1.233</td><td align="center" valign="middle" >0.290</td><td align="center" valign="middle" >0.565 - 6.738</td></tr><tr><td align="center" valign="middle" >Infer I</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Illegal abortions</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1 - 2</td><td align="center" valign="middle" >1.460</td><td align="center" valign="middle" >1.169</td><td align="center" valign="middle" >0.636</td><td align="center" valign="middle" >0.303 - 7.014</td></tr><tr><td align="center" valign="middle" >≥3</td><td align="center" valign="middle" >1 (omitted)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >None</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >BMI (Kg/m<sup>2</sup>)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >18.5 - 24.9</td><td align="center" valign="middle" >0.108</td><td align="center" valign="middle" >0.139</td><td align="center" valign="middle" >0.085</td><td align="center" valign="middle" >0.008 - 1.353</td></tr><tr><td align="center" valign="middle" >25 - 29.9</td><td align="center" valign="middle" >0.057</td><td align="center" valign="middle" >0.077</td><td align="center" valign="middle" >0.033</td><td align="center" valign="middle" >0.004 - 0.795</td></tr><tr><td align="center" valign="middle" >≥30</td><td align="center" valign="middle" >0.308</td><td align="center" valign="middle" >0.421</td><td align="center" valign="middle" >0.389</td><td align="center" valign="middle" >0.021 - 4.485</td></tr><tr><td align="center" valign="middle" >&lt;18.5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Endometrial biopsy</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Functional abnormalies</td><td align="center" valign="middle" >0.437</td><td align="center" valign="middle" >0.333</td><td align="center" valign="middle" >0.278</td><td align="center" valign="middle" >0.982 - 1.948</td></tr><tr><td align="center" valign="middle" >Endometritis</td><td align="center" valign="middle" >11.837</td><td align="center" valign="middle" >19.932</td><td align="center" valign="middle" >0.142</td><td align="center" valign="middle" >0.436 - 321.057</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Spermogram</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Oligospermia</td><td align="center" valign="middle" >0.970</td><td align="center" valign="middle" >0.908</td><td align="center" valign="middle" >0.974</td><td align="center" valign="middle" >0.154 - 6.084</td></tr><tr><td align="center" valign="middle" >Oligoasthenozoospermia</td><td align="center" valign="middle" >0.521</td><td align="center" valign="middle" >0.355</td><td align="center" valign="middle" >0.339</td><td align="center" valign="middle" >0.137 - 1.979</td></tr><tr><td align="center" valign="middle" >OAT</td><td align="center" valign="middle" >1 (omitted)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Azoospermia</td><td align="center" valign="middle" >1 (omitted)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >Infertility duration (years)</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >1</td><td align="center" valign="middle" >1.951</td><td align="center" valign="middle" >1.777</td><td align="center" valign="middle" >0.463</td><td align="center" valign="middle" >0.327 - 11.627</td></tr><tr><td align="center" valign="middle" >2</td><td align="center" valign="middle" >1.736</td><td align="center" valign="middle" >1.490</td><td align="center" valign="middle" >0.520</td><td align="center" valign="middle" >0.322 - 9.337</td></tr><tr><td align="center" valign="middle" >3 - 5</td><td align="center" valign="middle" >1.416</td><td align="center" valign="middle" >1.127</td><td align="center" valign="middle" >0.662</td><td align="center" valign="middle" >0.297 - 6.737</td></tr><tr><td align="center" valign="middle" >&gt;5</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >HSG</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr><tr><td align="center" valign="middle" >BTO</td><td align="center" valign="middle" >0.406</td><td align="center" valign="middle" >0.274</td><td align="center" valign="middle" >0.183</td><td align="center" valign="middle" >0.108 - 1.528</td></tr><tr><td align="center" valign="middle" >UTO</td><td align="center" valign="middle" >3.656</td><td align="center" valign="middle" >3.551</td><td align="center" valign="middle" >0.182</td><td align="center" valign="middle" >0.544 - 24.537</td></tr><tr><td align="center" valign="middle" >Others</td><td align="center" valign="middle" >0.112</td><td align="center" valign="middle" >0.123</td><td align="center" valign="middle" >0.046</td><td align="center" valign="middle" >0.013 - 0.965</td></tr><tr><td align="center" valign="middle" >Normal</td><td align="center" valign="middle" >1</td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td><td align="center" valign="middle" ></td></tr></tbody></table></table-wrap><p>The mean duration of infertility was ranged from 1 to 25 Years with an average of 4.3 &#177; 3.7 years, comparable to our findings in 2011 [<xref ref-type="bibr" rid="scirp.94942-ref19">19</xref>] and Stacey in USA among blacks patients and Hispanics in comparison with white American and those of Chinese origin [<xref ref-type="bibr" rid="scirp.94942-ref23">23</xref>] . The long duration of infertility could be explained not only by ignorance and poverty, but mostly by the patients’ itinerary. They go for alternative medecine (traditional medicine providers) first before relying on western medicine [<xref ref-type="bibr" rid="scirp.94942-ref19">19</xref>] .</p><p>2) Conception after Management</p><p>Nine percent of infertile patients conceived (clinical pregnancy). Considering only the patients who persevered to the beginning of paraclinical investigation (HSG), (1219 patients), the conception rate climbed to 11.09%. In comparison to Western ARTs centers results, that rate is, naturally very low [<xref ref-type="bibr" rid="scirp.94942-ref11">11</xref>] . No conception occurred in patients, whose partners were azoospermia or with OAT and the ones with history of tubal reparative surgery.</p><p>The mean age of the conception group (31.3 &#177; 5.7 years) was significantly (p = 0.000) lower than controls (33.4 &#177; 5.6 years). Conception rate was 11% in group of patients less than 36 years old and 4% above. Considering the association between conception and predictors, the patients less than 36 years old had three times more chance to conceive than those above (p = 0.000). Noticed in univariate analysis, that association persisted in the multivariate analysis. Adjusted with other predictors effects, patients of less than 25 years old had 24 times more chance to conceive than those above 35 years old (p = 0.017). That is consistent with the progressive decrease of female fertility from age of 30 according to Broeckmans et al., 2007 curve [<xref ref-type="bibr" rid="scirp.94942-ref24">24</xref>] . This is mainly explained by ovarian ageing and the occurrence of pathologies related to female ageing, like myomas and endometriosis [<xref ref-type="bibr" rid="scirp.94942-ref25">25</xref>] . And we have to take in account, the high risk of tubal infertility due to risky sexual behavior (STI and VIH) of patients before maternity desire, illustrated by a high rate of illegal abortion.</p><p>The rate of conception declined significantly (p = 0.000) with the duration of infertility: 21.5% for patients with one year and 6.9% for patients of more than 5 years. Furthermore, patients seeking infertility care after one, two and 3 - 5 years clusters had respectively 4, 3 and 2 times more chance to conceive in comparison with those who consulted more later (p = 0.000 and p = 0.062). That decreasing of the chance of conception is consistent with the decrease of fecundability according to the duration of fertility as stated by Schwartz [<xref ref-type="bibr" rid="scirp.94942-ref26">26</xref>] . Indeed, if the fecundability is around 25% at the beginning [<xref ref-type="bibr" rid="scirp.94942-ref24">24</xref>] , it falls by 16% after 6 months, 8% after 2 years and 4% after 5 years. That could be explained by the fact that longer is the duration of infertility, more likely the patients are aged. According to previous study in France, 44% of infertile women aged more than 40 years had more than six years of infertility. In addition, female and male gametes alterations and the reduction of intercourse frequency by ageing reduce the chance of conception per cycle [<xref ref-type="bibr" rid="scirp.94942-ref27">27</xref>] .</p><p>The mean age of the partners case (37.8 &#177; 5.7 years) was significantly lesser (p = 0.000) than the controls (40.5 &#177; 6.0 years). The patients whose male partners were lesser than 41 years old had three times more chance to conceive than the elder ones (p = 0.05). That situation can be explained by the decrease of the sperm quality with the age, because of the alteration of spermatogenesis and vascularization related to testicular ageing. It is reported the decrease of Leidig cell number with reduction of testosterone production and increase of tissue fibrosis [<xref ref-type="bibr" rid="scirp.94942-ref28">28</xref>] .</p><p>In the USA, Fisch et al., 1996 noticed the reduction of sperm motility of 0.17% from the age of 30 years [<xref ref-type="bibr" rid="scirp.94942-ref29">29</xref>] . Furthermore, Anger et al., 1995 noticed the decrease of sperm motility of 0.6% to 12% and the increase of sperm abnormal form, from 0.9% to 18% between 30 to 50 years [<xref ref-type="bibr" rid="scirp.94942-ref30">30</xref>] .</p><p>The majority (51.7%) of the patients who conceived were norm weighted, a few (13.9%) were obese and underweighted (2.8%). Compared to underweighted patients, the chance of conception decreased by 50% (p = 0.002) for overweighed and 60% (p = 0.003) for obese. Furthermore, adjusted to other factors, overweight reduced the chance of conception by 95% (p = 0.033) compared to underweighted patients. Age of the patients seemed to explain partially that observation. Indeed, 75% of underweighted patients were younger than the overweighed and obese, who were older than 35 years. Gensik et al., 2007 [<xref ref-type="bibr" rid="scirp.94942-ref31">31</xref>] and Brewer et al., 2010 [<xref ref-type="bibr" rid="scirp.94942-ref32">32</xref>] in USA, noticed the reduction of the chance of conception by 18% among over weighted and obese patients in comparison with the norm weighted (OR = 0.92 and 0.82).</p><p>A tenth (11.03%) of patients with bilateral tubal occlusion conceived after treatment. In the current study, the main treatment of tubal occlusion was hydrotubation, which was also a treatment associated with conception. The occurring of conception in this situation poses also the problem of the validity of HSG findings compared to the laparoscopic ones [<xref ref-type="bibr" rid="scirp.94942-ref33">33</xref>] Indeed, in all studies related to this aspect it was noticed that HSG was more specific than sensible, with a high rate of false positive results [<xref ref-type="bibr" rid="scirp.94942-ref33">33</xref>] .</p><p>No conception had been noticed among couple whose male partner had OAT and azoospermia; situations that can be resolved quasi exclusively by ART [<xref ref-type="bibr" rid="scirp.94942-ref34">34</xref>] .</p><p>Among the patients who conceived, 37.5% had genital infection as main diagnosis followed by the ones without any diagnosis (24.8%), and there were 12% with hyperprolactinemia and 11.4% each with myoma and ovarian dystrophy.</p><p>Genital infection was the most frequent diagnosis for all patients (46.4%). Furthermore, almost half of partner spermogram had leucocytospermia (46.4%) and the majority (52.84%) had other spermogram abnormalities associated with leucocytospermia, the best stigma of infection. It is well known that infection and its consequences (tubo-peritoneal, ovarian dysfonction) were the main responsible of infertility in subsaharan setting [<xref ref-type="bibr" rid="scirp.94942-ref7">7</xref>] .</p><p>Antibiotherapy was the most frequent treatment immediately associated with conception apart from some conception that occurred after some old fashioned techniques like hydrotubation.</p><p>The limit of the current study is its retrospective design, that could not allow to explore some predictors; Despite this weakness, in the other hand its strength is the huge number of patients.</p></sec><sec id="s5"><title>5. Conclusion</title><p>In conclusion, to take care of infertile couple out of ART, the conception is more likely to occur in patients aged less than 36 years, with infertility duration less than 3 years, normal weighted, without history of illegal abortion and tubal surgery, suffering from genital infection; a partner of less than 41 years old, without OAT and azoospermia. The main treatment closely related to conception was antibiotics, followed by hydrotubation and ovarian induction.</p></sec><sec id="s6"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest regarding the publication of this paper.</p></sec><sec id="s7"><title>Cite this paper</title><p>Mboloko, E., Apangwa, A.N., Nzau-Ngoma, E., Mboloko, M., Malingisi, B.G., Bikuelo, B.C.J., Kapend, M.M.M. and Mputu, L. (2019) Getting Pregnant after Infertility Management without Assisted Reproductive Technology in a Low-Income Setting. Open Journal of Obstetrics and Gynecology, 9, 1250-1264. https://doi.org/10.4236/ojog.2019.99121</p></sec></body><back><ref-list><title>References</title><ref id="scirp.94942-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Nana, P.N., Wandji, J.C., Rfornulu, J.N., Mbu, R.E., Leke, R.J.I. and Woubibwou, J.M. (2011) Aspect psycho-sociaux chez les patientes infertiles à la Maternité Principale de l’Hopital Central de Yaoundé. Clinics in Mother and Child Health, 8, C100601. https://doi.org/10.4303/cmch/C100601</mixed-citation></ref><ref id="scirp.94942-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">Okonofua, F.E. (1996) The Case against New Reproductive Technologies in Developing Countries. British Journal of Obstetrics and Gynaecology, 103, 957-962.  
https://doi.org/10.1111/j.1471-0528.1996.tb09542.x</mixed-citation></ref><ref id="scirp.94942-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2004) Infecundity, Infertility and the Childlessness in Developing Countries. Demographic and Health Surveys (DHS) Comparative Report No. 9. WHO, Geneva, 74.</mixed-citation></ref><ref id="scirp.94942-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Boivin, J., Bunting, L., Collins, J.A. and Nygren, K.G. (2007) International Estimates of Infertility Prevalence and Treatment-Seeking: Potential Need and Demand for Infertility Medical Care. Human Reproduction, 22, 1506-1512.  
https://doi.org/10.1093/humrep/dem046</mixed-citation></ref><ref id="scirp.94942-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Fathalla, M.F. (1992) Reproductive Health: A Global Overview. Early Human Development, 29, 35-42. https://doi.org/10.1016/0378-3782(92)90055-L</mixed-citation></ref><ref id="scirp.94942-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Ombelet, W., Cooke, I., Dyer, S., Serour, G. and Devroey, P. (2008) Infertility and the Provision of Infertility Medical Services in Developing Countries. Human Reproduction, 14, 605-621. https://doi.org/10.1093/humupd/dmn042</mixed-citation></ref><ref id="scirp.94942-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Gwet Bell, E. (2013) Traitement médical de la femme infertile en Afrique. Reproduction Humaine et Hormones, 3-4, 50-58.</mixed-citation></ref><ref id="scirp.94942-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization. Global Prevalence of Infertility, Infecundity and Childlessness. http://www.who.int/reproductivehealth/topics/infertility/burden/en</mixed-citation></ref><ref id="scirp.94942-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Mahmoud, A. L’infertilité au Maghreb: Aspect Statistiques.  
http://www.3cetudes.com/news/Infertilite au Maghreb aspect statistique.pdf</mixed-citation></ref><ref id="scirp.94942-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Nachtigall, R.D. (2006) International Disparities in Access to Infertility Services. Fertility and Sterility, 85, 871-875. https://doi.org/10.1016/j.fertnstert.2005.08.066</mixed-citation></ref><ref id="scirp.94942-ref11"><label>11</label><mixed-citation publication-type="other" xlink:type="simple">Mayenga, J.M. (2013) Quelle technique d’assistance médicale à la procréation pour l’Afrique? Reproduction Humaine et Hormones, 3-4, 96-103.</mixed-citation></ref><ref id="scirp.94942-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">United Nations (1995) Report of the International Conference on Population and Development, Cairo, Egypt, 5-13 September 1994. United Nation Population Fund, New York, E. 95. XIII. 18.</mixed-citation></ref><ref id="scirp.94942-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Howard, W.J., Cooke, I., Kempers, R., Brinsden, P. and Sauders, D. (2010) International Federation of Fertility Societies IFFS Surveillance.</mixed-citation></ref><ref id="scirp.94942-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">L’aide Médicale à la Procréation.  
http://www.chu-tours.fr/site_public/infos_sante/amp.html</mixed-citation></ref><ref id="scirp.94942-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Horde, P. Connaitre le taux de réussite des FIV dans les centres de PMA.  
http://www.Santé-Médecine.net, 2003-12-4.</mixed-citation></ref><ref id="scirp.94942-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Murage, A., Muteshi, M.C. and Githae, F. (2011) Assisted Reproduction Services Provision in a Developing Country: Time to Act? Fertility and Sterility, 96, 966-968.  
https://doi.org/10.1016/j.fertnstert.2011.07.1109</mixed-citation></ref><ref id="scirp.94942-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Moreira, P., Fall, C., Dieng, T., Fall, A., Diouf, A. and Moreau, J.C. (2008) Assistance Médicale à la procréation: Indication et perception par les couples présentant une infertilité au centre hospitalier universitaire de Dakar. Mali Médical, 23, 50-56.</mixed-citation></ref><ref id="scirp.94942-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">World Health Organization (2000) Obesity: Preventing and Managing the Global Epidemic. WHO, Geneva, 894.</mixed-citation></ref><ref id="scirp.94942-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Mboloko, E., Nzau, N.E. and Lokengo, L. (2011) itinéraire de la femme kinoise à la recherche des soins d’infertilité. Annals of African Medicine, 4, 855-863.</mixed-citation></ref><ref id="scirp.94942-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Mboloko, E.J., Yanga, K., Nguma, M., Lusanba, D., Kabwe, M., Tshiamu, B., et al. (1996) Les lésions tubaires et péritonéales à la coelioscopie chez les femmes stériles aux cliniques universitaires de Kinshasa. Panorama Médical, 1, 796-796.</mixed-citation></ref><ref id="scirp.94942-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Cissé, C.T., Cissé, M.L., Moréira, I.V., Dionne, P. and Diadhou, F. (1997) Maladies sexuellement transmissibles et stérilité féminine au CHU de Dakar: Prise en charge et moyens de prévention. Concept Fertil Sex, 25, 58-63.</mixed-citation></ref><ref id="scirp.94942-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Belaisch-Allart, J., et al. (2009) Infertilité dite inexpliquée: Quel bilan en 2009? Collège National des Gynécologues et Obstétriciens francais. Extrait des mises à jour en Gynécologie Médicale. 7-19.</mixed-citation></ref><ref id="scirp.94942-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Stacey, A., Misser, Sc.D., David, B.S. and Tarun, J. (2011) Cultural Factors Contributing to Health Care Disparities among Patients with Infertility in Midwestern States. Fertility and Sterility, 95, 1943-1949.  
https://doi.org/10.1016/j.fertnstert.2011.02.039</mixed-citation></ref><ref id="scirp.94942-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Broekmans, F.J., Knauff, A.H., Egbert, R., Veide, T., Macklon, N.S. and Fauser, B.C. (2007) Female Reproductive Ageing: Current Knowledge and Future Trends. Trends in Endocrinology and Metabolism, 18, 58-65.  
https://doi.org/10.1016/j.tem.2007.01.004</mixed-citation></ref><ref id="scirp.94942-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Mboloko, E., Muhindo, M., Ingala, A., Nzau, N.E., Lokengo, L.D., Bikuelo, B., Kapend, M.M.M. and Mboloko, M. (2017) Uterine Leiomyoma in an Infertile Population in Kinshasa (DR Congo). Annals of African Medicine, 10, 2635-2642.</mixed-citation></ref><ref id="scirp.94942-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Schwartz, D. (1981) Importance de la durée d’infécondité dans l’appréciation de la fertilité du couple. Population, 2, 237-250. https://doi.org/10.2307/1532547</mixed-citation></ref><ref id="scirp.94942-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Zorn, J.R. and Savale, M. (2005) Stérilité du couple: Assistance Médicale à la Procréation. Masson, Paris, 19,285-320.</mixed-citation></ref><ref id="scirp.94942-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Belaisch-Allart, J. (2002) Désir de grossesse et déclin de la fertilité. Collège National des Gynécologues et Obstétriciens francais. Extrait des mises à jour en Gynécologie Médicale. 60-71.</mixed-citation></ref><ref id="scirp.94942-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Fisch, H., Goluboff, E., Olson, J., Feldshuh, J., Broder, S. and Barad, D. (1996) Semen Analyses in 1283 Men from the United States over a 25-Years Period: No Decline in Quality. Fertility and Sterility, 65, 1009-1014.  
https://doi.org/10.1016/S0015-0282(16)58278-8</mixed-citation></ref><ref id="scirp.94942-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Auger, J., Kunstmann, J.M., Czyglik, F. and Jouannet, P. (1995) Decline in Semen Quality among Fertile Men in Paris during the Past 20 Years. The New England Journal of Medicine, 332, 281-285. https://doi.org/10.1056/NEJM199502023320501</mixed-citation></ref><ref id="scirp.94942-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Gesink Law, D.C., Maclehose, R.F. and Longnecker, M.P. (2007) Obesity and Time to Pregnancy. Human Reproduction, 22, 414-420.  
https://doi.org/10.1093/humrep/del400</mixed-citation></ref><ref id="scirp.94942-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Brewer, J.C. and Baleen, A.H. (2010) The Adverse Effects of Obesity on Conception and Implantation. Reproduction, 140, 347-364.  
https://doi.org/10.1530/REP-09-0568</mixed-citation></ref><ref id="scirp.94942-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Mboloko, E.J., Yanga, K., Nguma, M., Mputu, L. and Wolomby, M. (1998) La validité des résultats de l’hystérosalpingographie dans l’exploration de la stérilité du couple aux Cliniques Universitaires de Kinshasa. Congo Médical, 2, 408-411.</mixed-citation></ref><ref id="scirp.94942-ref34"><label>34</label><mixed-citation publication-type="book" xlink:type="simple">Davuluri, S. (2018) Current Trends in Management of Azoospermia and Oligoasthenospermia. In: Rao, K.A., Ed., The Infertility Manual, Jaypee Brothers Medical Publishers, New Delhi, 140-145.</mixed-citation></ref></ref-list></back></article>